New Rheumatology Tools Now Available for Oscar Users! More information ….
New tools have recently been developed by Dr. Henry Averns through the support of the ORA. Visit rheumors.com/oscar-resources for more information including web-based Arthritis Assessment forms, Disease Outcome Measures, Calculators and more. […]
Update on Naproxen Suspension
Naproxen suspension has been relisted on Ontario Drug Benefits plan […]
Triple therapy for RA now approved for EAP
The Exceptional Access Program has decided to accept failure of 3 months of standard triple therapy (MTX 20 mg qweekly, Sulfasalzine 2 gm/day and Plaquenil 400 mg daily) as equivalent to failure of […]
Update on Sulfasalazine shortage
The Sulfasalazine ENTERIC by PMS (generic) is on back order until April 9, 2015. The Sulfasalazine plain by PMS is available. The Sulfasalazine EN tablets by PFIZER are on backorder but according to […]
How to change your billing from internal medicine to rheumatology
Changes to OHIP fee schedule now make billing as a rheumatologist much more compelling. The process to switch your billing status with OHIP is available here. […]
Congratulations to Dr. Carter Thorne!
Dr. Carter Thorne is the 2015 Recipient of the Canadian Rheumalotogy Association’s Distinguished Rheumatologist Award. Read the full article … […]
Important Update Regarding EAP Criteria for Rituxan in Adult RA
Important EAP Update Regarding Rituxan in Adult RA! Read more … […]
Stand up and be counted
The Canadian Rheumatology Association is determining the actual number of rheuamtologists in Canada. There will be surveys sent during the year and a booth will be up at the CRA in Quebec City […]
EMR User Forum
On January 15, Dr. Vandana Ahluwalia and the EMR committee hosted an EMR forum to a well-attended group of Rheumatologists, Office Staff and AHPs. A copy of Dr. Ahluwalia’s presentation may be found […]
Drug shortage persists
Salazopyrin Enteric coated from Pfizer and generic leflunomide continue to part of ongoing drugs shortage. More news to follow once we have further information. Click here for source document and web resource […]
